AML-256 A Phase 1 Study of Gilteritinib in Combination With Induction and Consolidation Chemotherapy in Patients With Newly Diagnosed Acute Myeloid Leukemia: Final Study Results

Autor: Pratz, Keith W. 1, Cherry, Mohamad 2, Podoltsev, Nikolai A. 3, Altman, Jessica K. 4, Perl, Alexander E. 5, Cooper, Brenda W. 6, Jurcic, Joseph G. 7, Lin, Tara L. 8, Schiller, Gary J. 9, Wu, Ruishan 10, Hill, Jason E. 10, Gill, Stanley C. 10, James, Angela 10, Rich, Elizabeth Shima 10, Hasabou, Nahla 10, Levis, Mark J. 1
Zdroj: In Clinical Lymphoma, Myeloma and Leukemia October 2022 22 Supplement 2:S230-S230
Databáze: ScienceDirect
Externí odkaz: